Envestnet Asset Management
INSP icon

Envestnet Asset Management’s Inspire Medical Systems INSP Stock Holding History

Envestnet Asset Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,566
Closed -$1.37M – 4891
2026
Q1 		$1.37M Buy
26,566
+10,113
+61% +$708K ﹤0.01% 3277
2025
Q4 		$1.52M Buy
16,453
+4,335
+36% +$415K ﹤0.01% 3029
2025
Q3 		$899K Sell
12,118
-19,776
-62% -$2M ﹤0.01% 3391
2025
Q2 		$4.14M Sell
31,894
-2,257
-7% -$327K ﹤0.01% 2316
2025
Q1 		$5.44M Buy
34,151
+8,484
+33% +$1.53M ﹤0.01% 2067
2024
Q4 		$4.76M Buy
25,667
+1,752
+7% +$340K ﹤0.01% 2131
2024
Q3 		$5.05M Sell
23,915
-2,284
-9% -$397K ﹤0.01% 2101
2024
Q2 		$3.51M Sell
26,199
-5,000
-16% -$946K ﹤0.01% 2264
2024
Q1 		$6.7M Buy
31,199
+4,309
+16% +$845K ﹤0.01% 1780
2023
Q4 		$5.47M Sell
26,890
-3,172
-11% -$514K ﹤0.01% 1829
2023
Q3 		$5.97M Buy
30,062
+8,711
+41% +$2.2M ﹤0.01% 1684
2023
Q2 		$6.93M Sell
21,351
-210,070
-91% -$60M ﹤0.01% 1513
2023
Q1 		$4.59M Buy
231,421
+212,406
+1,117% +$53.7M ﹤0.01% 1695
2022
Q4 		$4.79M Sell
19,015
-338
-2% -$72.1K ﹤0.01% 1635
2022
Q3 		$3.43M Buy
19,353
+475
+3% +$95.5K ﹤0.01% 1732
2022
Q2 		$3.45M Buy
18,878
+114
+0.6% +$22.7K ﹤0.01% 1745
2022
Q1 		$4.82M Buy
18,764
+973
+5% +$222K ﹤0.01% 1628
2021
Q4 		$4.09M Buy
17,791
+2,377
+15% +$580K ﹤0.01% 1706
2021
Q3 		$3.59M Buy
15,414
+3,017
+24% +$630K ﹤0.01% 1725
2021
Q2 		$2.4M Buy
12,397
+2,266
+22% +$449K ﹤0.01% 1938
2021
Q1 		$2.1M Buy
10,131
+5,349
+112% +$1.14M ﹤0.01% 1907
2020
Q4 		$899K Buy
4,782
+1,115
+30% +$182K ﹤0.01% 2286
2020
Q3 		$473K Buy
3,667
+758
+26% +$83.5K ﹤0.01% 2497
2020
Q2 		$253K Buy
+2,909
New +$224K ﹤0.01% 2768
2020
Q1 		– Sell
-2,901
Closed -$215K – 3055
2019
Q4 		$215K Buy
+2,901
New +$186K ﹤0.01% 2893

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Envestnet Asset Management's INSP Position: Q2 2026 in Review

Envestnet Asset Management sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 26,566 shares — an estimated $1.37M sold.

Envestnet Asset Management first reported a position in INSP in Q4 2019 and held it in 25 quarters. The position peaked at $6.93M in Q2 2023. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Envestnet Asset Management reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 26,566 Inspire Medical Systems shares in Q2 2026, an estimated $1.37M.
  • Envestnet Asset Management first reported a position in Inspire Medical Systems in Q4 2019 and held it in 25 quarters.
  • Envestnet Asset Management's Inspire Medical Systems position peaked at $6.93M in Q2 2023.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.